Amkay Products Ltd vs Clinitech Laboratory Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Amkay Products Ltd is ₹ 53.5 as of 23 Oct 15:30 . The P/E Ratio of Amkay Products Ltd is 0 as of March 2025 .The P/E Ratio of Clinitech Laboratory Ltd is 23.3 as of March 2025 . The Market Cap of Amkay Products Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Clinitech Laboratory Ltd is ₹ 9.18 crore as of March 2025 . The Dividend Payout of Amkay Products Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Clinitech Laboratory Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Amkay Products Ltd

Amkay Products Limited was originally incorporated as 'Amkay Products Private Limited' on October 25, 2007 with the Registrar of Companies, Mumbai.
Subsequently, the Company was converted into a Public Limited Company and the name was changed from 'Amkay Products Private Limited' to 'Amkay Products Limited' vide a fresh Certificate of Incorporation dated August 28, 2023, issued by the Registrar of Companies, Maharashtra, Mumbai. The Company manufacture, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Steel/ Plastic Lancet Needles, Air Bed, Apron, Digital Thermometer, Nebulizer, Shoe Cover, BP Monitor, Pulse Oximeter, Surgeon Cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. widely spread across India.

About Clinitech Laboratory Ltd

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai.
The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.
Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018.
Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests.

FAQs for the comparison of Amkay Products Ltd and Clinitech Laboratory Ltd

Which company has a larger market capitalization, Amkay Products Ltd or Clinitech Laboratory Ltd?

Market cap of Amkay Products Ltd is 46 Cr while Market cap of Clinitech Laboratory Ltd is 7 Cr

What are the key factors driving the stock performance of Amkay Products Ltd and Clinitech Laboratory Ltd?

The stock performance of Amkay Products Ltd and Clinitech Laboratory Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amkay Products Ltd and Clinitech Laboratory Ltd?

As of October 25, 2026, the Amkay Products Ltd stock price is INR ₹53.5. On the other hand, Clinitech Laboratory Ltd stock price is INR ₹32.0.

How do dividend payouts of Amkay Products Ltd and Clinitech Laboratory Ltd compare?

To compare the dividend payouts of Amkay Products Ltd and Clinitech Laboratory Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.